DM

Deerfield Management Portfolio holdings

AUM $5.51B
This Quarter Return
-3.39%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.78B
AUM Growth
+$2.78B
Cap. Flow
+$268M
Cap. Flow %
9.65%
Top 10 Hldgs %
39.18%
Holding
111
New
16
Increased
25
Reduced
19
Closed
12

Top Buys

1
VTRS icon
Viatris
VTRS
$81.2M
2
AERI
Aerie Pharmaceuticals, Inc.
AERI
$42.1M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$38.4M
4
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
$37.1M
5
STAA icon
STAAR Surgical
STAA
$25.8M

Top Sells

1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$90.8M
2
CNC icon
Centene
CNC
$19.1M
3
GKOS icon
Glaukos
GKOS
$17.9M
4
AXGN icon
Axogen
AXGN
$17.3M
5
ASND icon
Ascendis Pharma
ASND
$17M

Sector Composition

1 Healthcare 67.78%
2 Financials 0.96%
3 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MOR
51
DELISTED
MorphoSys AG American Depositary Shares
MOR
$14.5M 0.52%
600,000
– –
RYTM icon
52
Rhythm Pharmaceuticals
RYTM
$6.86B
$13.7M 0.49%
623,933
+332,928
+114% +$7.32M
DCPH
53
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$13.7M 0.49%
607,633
– –
GLPG icon
54
Galapagos
GLPG
$2.05B
$13M 0.47%
101,010
-75,948
-43% -$9.79M
GBT
55
DELISTED
Global Blood Therapeutics, Inc.
GBT
$12.4M 0.44%
+235,000
New +$12.4M
ATNX
56
DELISTED
Athenex, Inc. Common Stock
ATNX
$12.3M 0.44%
621,859
– –
SYRS
57
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11.8M 0.42%
1,268,946
+1
+0% +$9
TPTX
58
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$11.7M 0.42%
+287,545
New +$11.7M
PHAS
59
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$11.2M 0.4%
+851,005
New +$11.2M
SYBX icon
60
Synlogic
SYBX
$17.2M
$10.1M 0.36%
1,107,643
– –
TNDM icon
61
Tandem Diabetes Care
TNDM
$841M
$9.84M 0.35%
152,500
+117,000
+330% +$7.55M
ARDX icon
62
Ardelyx
ARDX
$1.55B
$9.31M 0.33%
3,461,298
+177,000
+5% +$476K
INSP icon
63
Inspire Medical Systems
INSP
$2.56B
$9.17M 0.33%
151,106
+12,106
+9% +$734K
CHWY icon
64
Chewy
CHWY
$16.6B
$9.15M 0.33%
+261,337
New +$9.15M
ACRS icon
65
Aclaris Therapeutics
ACRS
$219M
$8.72M 0.31%
3,983,025
-1,910,391
-32% -$4.18M
XFOR icon
66
X4 Pharmaceuticals
XFOR
$70.5M
$8.48M 0.3%
+565,000
New +$8.48M
AVDL
67
Avadel Pharmaceuticals
AVDL
$1.39B
$7.87M 0.28%
2,722,241
– –
BBIO icon
68
BridgeBio Pharma
BBIO
$9.84B
$7.82M 0.28%
+290,000
New +$7.82M
SRNE
69
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$5.58M 0.2%
+2,091,461
New +$5.58M
ALIM
70
DELISTED
Alimera Sciences, Inc.
ALIM
$5.39M 0.19%
6,052,935
– –
IDYA icon
71
IDEAYA Biosciences
IDYA
$2.23B
$4.23M 0.15%
+425,000
New +$4.23M
BDSI
72
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3.8M 0.14%
+816,096
New +$3.8M
HARP
73
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3.71M 0.13%
285,000
– –
ITMR
74
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.46M 0.12%
314,136
– –
SYRE icon
75
Spyre Therapeutics
SYRE
$1.01B
$3.43M 0.12%
500,046
– –
1 2
3
4